Page 108 - TBE_Book_V2_2019
P. 108

Chapter 4: Pathogenesis of TBE


          74.  Kreil TR, Eibl MM. Pre- and postexposure   83.  Gelpi E, Preusser M, Garzuly F, Holzmann H,
             protection by passive immunoglobulin but no   Heinz FX, Budka H. Visualization of Central
             enhancement of infection with a flavivirus in a   European tick-borne encephalitis infection in
             mouse model. J Virol. 1997;71(4):2921-2927.   fatal human cases. J Neuropathol Exp Neurol.
                                                         2005;64(6):506-512.
          75.  Heinz FX, Berger R, Tuma W, Kunz C. A
             topological and functional model of epitopes   84.  Michlmayr D, Bardina SV, Rodriguez CA,
             on the structural glycoprotein of tick-borne   Pletnev AG, Lim JK. Dual Function of Ccr5
             encephalitis virus defined by monoclonal    during Langat Virus Encephalitis: Reduction in
             antibodies. Virology. 1983;126(2):525-537.   Neutrophil-Mediated Central Nervous System
                                                         Inflammation and Increase in T Cell-Mediated
          76.  Niedrig M, Klockmann U, Lang W, et al.    Viral Clearance. J Immunol. 2016;196(11):4622
             Monoclonal antibodies directed against tick-  -4631.
             borne encephalitis virus with neutralizing
             activity in vivo. Acta Virol. 1994;38(3):141-149.   85.  Zompi S, Harris E. Animal models of dengue
                                                         virus infection. Viruses. 2012;4(1):62-82.
          77.  Phillpotts RJ, Stephenson JR, Porterfield JS.
             Passive immunization of mice with monoclonal   86.  Dobler G, Bestehorn M, Antwerpen M, Overby
             antibodies raised against tick-borne        -Wernstedt A. Complete Genome Sequence of
             encephalitis virus. Brief report. Arch Virol.   a Low-Virulence Tick-Borne Encephalitis Virus
             1987;93(3-4):295-301.                       Strain. Genome Announc. 2016;4(5).
          78.  Kreil TR, Maier E, Fraiss S, Eibl MM.   87.  Asghar N, Lee YP, Nilsson E, et al. The role of
             Neutralizing antibodies protect against lethal   the poly(A) tract in the replication and
             flavivirus challenge but allow for the      virulence of tick-borne encephalitis virus. Sci
             development of active humoral immunity to a   Rep. 2016;6:39265.
             nonstructural virus protein. J Virol. 1998;72
             (4):3076-3081.                          88.  Kurhade C, Schreier S, Lee YP, et al. Correlation
                                                         of Severity of Human Tick-Borne Encephalitis
          79.  Cerwenka A, Morgan TM, Dutton RW. Naive,   Virus Disease and Pathogenicity in Mice.
             effector, and memory CD8 T cells in protection   Emerg Infect Dis. 2018;24(9):1709-1712.
             against pulmonary influenza virus infection:
             homing properties rather than initial   89.  Rice CM, Grakoui A, Galler R, Chambers TJ.
             frequencies are crucial. J Immunol. 1999;163  Transcription of infectious yellow fever RNA
             (10):5535-5543.                             from full-length cDNA templates produced by
                                                         in vitro ligation. New Biol. 1989;1(3):285-296.
          80.  Krylova NV, Smolina TP, Leonova GN.
             Molecular Mechanisms of Interaction Between   90.  Boyer JC, Haenni AL. Infectious transcripts and
             Human Immune Cells and Far Eastern Tick-    cDNA clones of RNA viruses. Virology.
             Borne Encephalitis Virus Strains. Viral     1994;198(2):415-426.
             Immunol. 2015;28(5):272-281.            91.  Aubry F, Nougairede A, Gould EA, de
                                                         Lamballerie X. Flavivirus reverse genetic
          81.  Blom K, Braun M, Pakalniene J, et al. Specificity
             and dynamics of effector and memory CD8 T   systems, construction techniques and
             cell responses in human tick-borne          applications: a historical perspective. Antiviral
             encephalitis virus infection. PLoS Pathog.   Res. 2015;114:67-85.
             2015;11(1):e1004622.                    92.  Mandl CW, Ecker M, Holzmann H, Kunz C,
                                                         Heinz FX. Infectious cDNA clones of tick-borne
          82.  Fujii Y, Hayasaka D, Kitaura K, Takasaki T,
             Suzuki R, Kurane I. T-cell clones expressing   encephalitis virus European subtype prototypic
             different T-cell receptors accumulate in the   strain Neudoerfl and high virulence strain
             brains of dying and surviving mice after    Hypr. J Gen Virol. 1997;78 ( Pt 5):1049-1057.
             peripheral infection with far eastern strain of   93.  Gritsun TS, Gould EA. Infectious transcripts of
             tick-borne encephalitis virus. Viral Immunol.   tick-borne encephalitis virus, generated in
             2011;24(4):291-302.                         days by RT-PCR. Virology. 1995;214(2):611-
                                                         618.


                                                  103
   103   104   105   106   107   108   109   110   111   112   113